ArTS Archivio della ricerca di Trieste

BERGAMO, ALBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.592
EU - Europa 3.461
AS - Asia 1.367
SA - Sud America 20
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 12.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.578
PL - Polonia 625
UA - Ucraina 620
SE - Svezia 581
CN - Cina 480
IT - Italia 479
SG - Singapore 456
DE - Germania 267
HK - Hong Kong 238
FI - Finlandia 200
GB - Regno Unito 183
BG - Bulgaria 140
TR - Turchia 134
IE - Irlanda 122
RU - Federazione Russa 74
FR - Francia 73
CH - Svizzera 29
IN - India 16
BE - Belgio 14
EU - Europa 13
BR - Brasile 11
VN - Vietnam 11
CA - Canada 10
NL - Olanda 10
RO - Romania 9
SN - Senegal 8
AT - Austria 6
AU - Australia 5
ES - Italia 5
GR - Grecia 5
KR - Corea 5
RS - Serbia 5
AR - Argentina 4
HU - Ungheria 4
MY - Malesia 4
TH - Thailandia 4
CL - Cile 3
EG - Egitto 3
JP - Giappone 3
MX - Messico 3
NZ - Nuova Zelanda 3
CZ - Repubblica Ceca 2
HR - Croazia 2
ID - Indonesia 2
IR - Iran 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
PE - Perù 1
Totale 12.476
Salva come PNG Salva come JPEG
Città #
Ann Arbor 857
Fairfield 793
Woodbridge 752
Houston 657
Warsaw 619
Jacksonville 563
Chandler 509
Wilmington 461
Ashburn 455
Singapore 410
Seattle 331
Cambridge 268
Princeton 247
Hong Kong 234
Boardman 196
Beijing 164
Sofia 140
Trieste 127
Izmir 123
Dublin 120
Columbus 118
Santa Clara 104
Dearborn 94
San Diego 61
Milan 55
Bern 26
Verona 26
Hefei 25
Redwood City 25
Chicago 24
Phoenix 24
Falls Church 22
Des Moines 20
Nanjing 18
Norwalk 17
Helsinki 15
Brussels 14
Düsseldorf 14
Kunming 14
Dallas 11
Redmond 11
Costa Mesa 10
Dong Ket 10
Jinan 10
Los Angeles 10
Andover 9
Auburn Hills 9
North Bergen 9
Poplar 9
Buffalo 8
Dagenham 8
Dakar 8
Guangzhou 8
Mestre 8
Nanchang 8
Shanghai 8
Kocaeli 7
São Paulo 7
Fuzhou 6
New York 6
Wuhan 6
Zhengzhou 6
Athens 5
Fremont 5
Nanning 5
Seoul 5
Springfield 5
Tappahannock 5
Bremen 4
Budapest 4
Camerino 4
Kraków 4
Ottawa 4
Pavia 4
Pune 4
Scuola 4
Urbino 4
Vienna 4
Amsterdam 3
Atlanta 3
Belgrade 3
Cairo 3
Changsha 3
Dongguan 3
Ferrara 3
Hangzhou 3
Hebei 3
Indiana 3
Leawood 3
London 3
Mumbai 3
Napoli 3
Pisa 3
Rome 3
Taiyuan 3
Taizhou 3
Toronto 3
Xian 3
Berlin 2
Boydton 2
Totale 9.068
Salva come PNG Salva come JPEG
Nome #
Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin 311
Pharmacological activities of ruthenium complexes related to their NO scavenging properties 290
Chemical and Molecular Approach to Tumor Metastases 276
Influence of components of tumour microenvironment on the response of HCT-116 colorectal cancer to the ruthenium-based drug NAMI-A 211
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 190
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 176
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 168
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 165
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 163
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 162
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 159
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 151
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions 151
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 149
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 147
Ruthenium complexes can target determinants of tumour malignancy 146
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes 146
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model 144
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 143
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 141
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 141
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 140
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 134
Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine 134
New half sandwich Ru(II) coordination compounds for anticancer activity 134
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 133
Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion 133
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs 132
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 132
Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound 131
Down-regulation of tumor gelatinase/inhibitor balance and preservation of tumor endothelium by an anti-metastatic ruthenium complex. 131
Ruthenium drugs for cancer chemotherapy: an ongoing challenge to treat solid tumours 129
Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity 129
Tuning the hydrophobicity of ruthenium(ii)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy 128
Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells. 128
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 128
Complessi di Rutenio con elevata attività antitumorale 127
Synthesis and characterization of a diruthenium(II,III)-ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives 125
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 125
Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibition 122
Synthetic thymic fraction 5: Effects of high dose administration on circulating lymphocytes in patients 121
Novel water-soluble 99mTc(I)/Re(I)-porphyrin conjugates as potential multimodal agents for molecular imaging 121
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 118
Ruthenium dimeric compounds suitable as antimetastatic and antineoplastic agents 117
Photolabile RuIIHalf-Sandwich Complexes Suitable for Developing “Caged” Compounds: Chemical Investigation and Unexpected Dinuclear Species with Bridging Diamine Ligands 117
Modulation of Activity of Known Cytotoxic Ruthenium(III) Compound (KP418) with Hampered Transmembrane Transport in Electrochemotherapy In Vitro and In Vivo 116
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 116
Preclinical combination therapy of the investigational drug NAMI-A with doxorubicin for mammary cancer 114
Ruthenium-based compounds and tumour growth control (Review) 113
Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells 113
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 113
Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation 113
Influence of Hydrogen-Bonding Substituents on the Cytotoxicity of RAPTA Compounds 112
Linking the future of anticancer metal complexes to the therapy of tumour metastases 111
Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A 111
Ruthenium antimetastatic agents 109
Metal-based antitumour drugs in the post-genomic era: what comes next? 109
Age Dependent Modification of the Metabolic Profile of the Tibialis Anterior Muscle Fibers in C57BL/6J Mice 109
Ruthenium Anticancer Drugs 108
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion. 107
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 106
Synthesis, characterization and tumor cell growth inhibition of new transplatinum complexes with phosphane derivatives 105
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 105
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 104
Ruthenium complexes with high antitumoral and antimetastatic activities 103
Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen 103
Synthesis and Chemical-Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl [1,2,4]triazolo [1,5-a]pyrimidine) 102
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity 101
Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes. 99
DNA-adduct formation-guided design: thoughts about the future of metal based anticancer drugs 99
In vitro cell cycle arrest, in vivo action on solid metastasizing tumors and host toxicity of the antimetastatic drug NAMI-A and of cisplatin. 96
Long-term resveratrol treatment improves the capillarization in the skeletal muscles of ageing C57BL/6J mice 95
Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives. 94
Molecular structure, solution chemistry and biological properties of the novel [ImH][trans-IrCl(4)(Im)(DMSO)], (I) and of the orange form of [(DMSO)(2)H][trans-IrCl(4)(DMSO)(2)], (II), complexes. 93
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 92
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas 91
Approaching tumour therapy beyond platinum drugs. Status of the art and perspectives of ruthenium drug candidates. 90
Inhibition of endothelial cell functions and angiogenesis by the metastasis inhibitor NAMI-A 83
Hyperphosphorylation Maintenance Drives the Time-Course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in KB Cells 83
Identification and measurement of transferrin receptors in a T-cell lymphocyte population by a fluorescent ligand 82
New anionic and neutral complexes of Ru(III) with nitrogen oxide 80
Treatment of residual metastases with Na[trans-RuCl4(DMSO)Im) and ruthenium uptake by tumour cells 80
Modification of Lymphocytes of Peyer’s Patches-Mesentheric Lymphonodes Splean by Egg-White Lysozyme 80
Increase of tumour infiltrating lymphocytes in mice treated with antimetastatic doses of NAMI-A 80
Half-sandwich RuIIsingle bond[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: Preparation, structural characterization and in vitro cytotoxic activity 78
Tumor cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells 77
Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferring. 77
The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy 76
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data 73
Lysozyme-induced transcriptional regulation of tnf-α pathway genes in cells of the monocyte lineage 71
Tumour cell uptake, G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells 66
CD40 and CD95 induce programmed cell death in the human myeloma cell line XG2 65
In vitro cell cycle arrest,in vivo action on solid metastasizing tumors and host toxicity of the antimetastatic drug NAMI-A and cisplatin. 64
Ruthenium-porphyrin conjugates for anticancer activity 64
Biological Properties of Irim, the iridium(III) analogue of (imidazolium(bisimidazole)tetrachlororuthenate) (ICR) 64
Lack of in vitro cytotoxicity, associated to increased G2-M cell fraction and inhibition of matrigel invasion, may predict in vivo-selective antimetastasis activity of ruthenium complexes 61
Chitosan-coated alginate micro-particles delivery of active principles through conventional pelleted food - A study in Tilapia (Oreochromis niloticus) 58
Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process 57
Novel platinum pyridinehydroxamic acid complexes: synthesis, characterisation, X-ray crystallographic study and nitric oxide relaled properties 56
PHARMACOLOGICAL APPROACHES TO SARS-CoV-2 INFECTION: FROM DRUG REPOSITIONING FOR COVID-19 TREATMENT TO DISEASE ARREST/PREVENTION WITH MoAbs AND NOVEL ANTIVIRALS 54
Totale 11.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.682 0 0 0 0 155 304 240 352 244 130 186 71
2020/20211.782 168 97 164 271 130 210 104 153 64 184 52 185
2021/20221.276 49 103 64 128 22 96 71 56 172 137 103 275
2022/20231.589 181 179 124 202 155 297 3 152 199 10 64 23
2023/2024938 84 55 33 52 95 57 114 305 9 15 48 71
2024/20251.014 18 150 483 187 176 0 0 0 0 0 0 0
Totale 12.772